43 participants
A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2025-09-05
- Completion:
- 2027-09-01
Conditions
- Acute Myeloid Leukemia
Interventions
- DRUG
No Results Yet